Alopecia universalis and Graves' disease in the setting of immune restoration after highly active antiretroviral therapy.
Sereti
I
I
Sarlis
N J
NJ
Arioglu
E
E
Turner
M L
ML
Mican
J M
JM
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy; D000328:Adult; D000505:Alopecia / Q000139:chemically induced*; D019380:Anti-HIV Agents / Q000009:adverse effects* / Q000627:therapeutic use; D023241:Antiretroviral Therapy, Highly Active; D006111:Graves Disease / Q000139:chemically induced*; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy / Q000276:immunology / Q000821:virology; D017320:HIV Protease Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use
D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors; D018894:Reverse Transcriptase Inhibitors